Patents by Inventor Nan-Haw Chow

Nan-Haw Chow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TARGETED THERAPY COMPOSITION AND ITS USE FOR SUPPRESSING BREAST CANCER CELL PROLIFERATION, MIGRATION OR INVASION
    Publication number: 20230089224
    Abstract: The present invention discloses a targeted therapy composition and a method for suppressing breast cancer cell proliferation, migration or invasion by administrating the targeted therapy composition to a subject in need thereof. The composition comprises a type 3 epithelial membrane proteins (EMP3) targeted inhibitor. The breast cancer cells are characterized by upregulation of EMP3, EGFR, HER2, HER3, HR, or downregulation of HER4 gene expression. EMP3-targeting oligonucleotide or nuclease is administrated upon the breast cancer cells so as to degrade EMP3-coding DNA or mRNA, and to suppress breast cancer cell proliferation, migration or invasion.
    Type: Application
    Filed: September 7, 2022
    Publication date: March 23, 2023
    Inventors: Nan-Haw CHOW, Yi-Wen Wang, Yih-Lin Tuan, Yao-Lung Kuo
  • Computer aided method and electrical device for analyzing fibrosis
    Patent number: 11508060
    Abstract: A computer aided method for analyzing fibrosis is provided. First, a segmentation algorithm is performed on a medical image to obtain a segmentation image. Circular fibrosis is detected according to the segmentation image to determine a score. In some cases, it is also necessary to determine a number of fibrosis bridges and the condition of fiber expansion.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: November 22, 2022
    Assignee: NATIONAL CHENG KUNG UNIVERSITY
    Inventors: Pau-Choo Chung Chan, Nan-Haw Chow, Hung-Wen Tsai, Kuo-Sheng Cheng, Chun-Cheng Huang
  • Biomarker for prognosis of colorectal cancer
    Patent number: 11434537
    Abstract: Provided is a method of accurate and sensitive characterization and prognosis of colorectal cancer in a subject. The method includes obtaining a cancer tissue from the subject and determining the expression level of a miRNA and a target gene of the miRNA. Also provided is a kit for prognosis of colorectal cancer in a subject in need thereof.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: September 6, 2022
    Assignee: NATIONAL CHENG KUNG UNIVERSITY
    Inventors: Nan-Haw Chow, Chien-An Chu, Hsiao-Sheng Liu, Chung-Ta Lee
  • BIOMARKER FOR PROGNOSIS OF COLORECTAL CANCER
    Publication number: 20210262036
    Abstract: Provided is a method of accurate and sensitive characterization and prognosis of colorectal cancer in a subject. The method includes obtaining a cancer tissue from the subject and determining the expression level of a miRNA and a target gene of the miRNA. Also provided is a kit for prognosis of colorectal cancer in a subject in need thereof.
    Type: Application
    Filed: February 14, 2020
    Publication date: August 26, 2021
    Inventors: Nan-Haw Chow, Chien-An Chu, Hsiao-Sheng Liu, Chung-Ta Lee
  • COMPUTER AIDED METHOD AND ELECTRICAL DEVICE FOR ANALYZING FIBROSIS
    Publication number: 20200065965
    Abstract: A computer aided method for analyzing fibrosis is provided. First, a segmentation algorithm is performed on a medical image to obtain a segmentation image. Circular fibrosis is detected according to the segmentation image to determine a score. In some cases, it is also necessary to determine a number of fibrosis bridges and the condition of fiber expansion.
    Type: Application
    Filed: August 26, 2019
    Publication date: February 27, 2020
    Inventors: Pau-Choo CHUNG CHAN, Nan-Haw CHOW, Hung-Wen TSAI, Kuo-Sheng CHENG, Chun-Cheng HUANG
  • Regulator, pharmaceutical composition encompassing the regulator and application thereof
    Patent number: 9180139
    Abstract: The present disclosure is directed to a regulator, a pharmaceutical composition encompassing the regulator and the application thereof. The regulator modulates the expression integrins and/or EMP2, and is employed for treating integrins-associated and/or EMP2-associated diseases.
    Type: Grant
    Filed: May 14, 2013
    Date of Patent: November 10, 2015
    Assignee: National Cheng Kung University
    Inventors: Nan-Haw Chow, Hsiao-Sheng Liu, Yi-Wen Wang, Wen-Tsan Chang